<?xml version="1.0" encoding="UTF-8"?>
<ref id="B112-pharmaceuticals-13-00096">
 <label>112.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Molina</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Delaugerre</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Le Goff</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mela-Lima</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ponscarme</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Goldwirt</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>De Castro</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection</article-title>
  <source>Med. Mal. Infect.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1016/j.medmal.2020.03.006</pub-id>
  <?supplied-pmid 32240719?>
  <pub-id pub-id-type="pmid">32240719</pub-id>
 </element-citation>
</ref>
